Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New score may help doctors predict ICU outcomes for liver patients

NCT ID NCT06561477

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new scoring system called the Intensive Care Cirrhosis Outcome (ICCO) score to see how well it predicts survival in cirrhosis patients admitted to the ICU. Researchers calculated the score for 150 adult patients using routine lab tests and tracked their outcomes. The goal is to give doctors a simple, reliable tool to identify high-risk patients and improve care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the ICCO score proves accurate, doctors may have a better tool to predict which cirrhosis patients in the ICU are most at risk, helping guide treatment decisions.
What could go wrong
This is a small, single-center study that only tests a scoring system—it does not test a new treatment. The score may not work as well in other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

150 people

The number who actually took part.

Started

Mar 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients with confirmed diagnosis with liver cirrhosis admitted to the intensive care unit

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (age ≥18 years) with cirrhosis admitted to the ICU. * Confirmed diagnosis of cirrhosis based on clinical, radiological, and/or histological criteria. * Need for intensive care management due to acute illness or complications related to cirrhosis. Exclusion Criteria: * Patients without a confirmed diagnosis of cirrhosis. * Patients with acute liver failure not meeting criteria for cirrhosis. * Patients with incomplete data for calculating ICCO. * Patients transferred from another ICU. * Patients who refuse participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver cirrhosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cirrhosis of liver

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver cirrhosis

Contacts and locations

Locations

  • Assiut university hospitals

    Asyut, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.